Industry Strength Score
16/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
RXSIGHT INC (RXST) Stock Price & Overview
NASDAQ:RXST • US78349D1072
Current stock price
6.81 USD
-0.36 (-5.02%)
At close:
6.65 USD
-0.16 (-2.35%)
Pre-Market:
The current stock price of RXST is 6.81 USD. Today RXST is down by -5.02%. In the past month the price increased by 10.55%. In the past year, price decreased by -57.03%.
RXST Key Statistics
52-Week Range5.9 - 16.74
Current RXST stock price positioned within its 52-week range.
1-Month Range6.07 - 7.72
Current RXST stock price positioned within its 1-month range.
- Market Cap
- 281.049M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.95
- Dividend Yield
- N/A
RXST Stock Performance
Today
-5.02%
1 Week
-7.97%
1 Month
+10.55%
3 Months
-21.63%
Longer-term
6 Months -22.53%
1 Year -57.03%
2 Years -86.94%
3 Years -61.96%
5 Years N/A
10 Years N/A
RXST Stock Chart
RXST Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to RXST. When comparing the yearly performance of all stocks, RXST is a bad performer in the overall market: 92.67% of all stocks are doing better.
Chartmill TA Rating
Chartmill Setup Rating
RXST Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to RXST. While RXST seems to be doing ok healthwise, there are quite some concerns on its profitability.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
RXST Earnings
On February 25, 2026 RXST reported an EPS of -0.22 and a revenue of 32.61M. The company beat EPS expectations (35.1% surprise) and beat revenue expectations (6.15% surprise).
Next Earnings DateMay 6, 2026
Last Earnings DateFeb 25, 2026
PeriodQ4 / 2025
EPS Reported-$0.22
Revenue Reported32.607M
EPS Surprise 35.10%
Revenue Surprise 6.15%
RXST Forecast & Estimates
16 analysts have analysed RXST and the average price target is 10.26 USD. This implies a price increase of 50.72% is expected in the next year compared to the current price of 6.81.
For the next year, analysts expect an EPS growth of -42.16% and a revenue growth -1.83% for RXST
Analysts
Analysts52.5
Price Target10.26 (50.66%)
EPS Next Y-42.16%
Revenue Next Year-1.83%
RXST Index Membership
RXST is currently included in the following stock indexes tracked on ChartMill.
RXST Financial Highlights
Over the last trailing twelve months RXST reported a non-GAAP Earnings per Share(EPS) of -0.95. The EPS decreased by -31.94% compared to the year before.
Income Statements
Revenue(TTM)134.48M
Net Income(TTM)-38.94M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -12.49% | ||
| ROE | -14.13% | ||
| Debt/Equity | 0 |
Chartmill High Growth Momentum
EPS Q2Q%-46.67%
Sales Q2Q%-18.92%
EPS 1Y (TTM)-31.94%
Revenue 1Y (TTM)-3.89%
RXST Ownership
Ownership
Inst Owners90.03%
Shares41.27M
Float38.66M
Ins Owners5.55%
Short Float %14.42%
Short Ratio7.39
RXST Industry Overview
RXST operates in the Health Care Supplies sub-industry within the Health Care sector. This group contains 34 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Growth Score
34/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
14%
Outperformed 14% of sub-industries
3 Month Rank
14%
Outperformed 14% of sub-industries
6 Month Rank
22%
Outperformed 22% of sub-industries
Industry Fundamentals & Breadth
- Members
- 34
- New Highs
- 2.9%
- New Lows
- 14.7%
- Average ROE
- 12.6%
- Average Profit Margin
- 7.9%
- Average Operating Margin
- 10.8%
- Average P/E
- 24.1
- Average Fwd P/E
- 21.2
- Average Debt/Equity
- 0.9
RXST Competitors/Peers
The largest stocks on the US markets in the "Health Care Supplies" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| MDLN | MEDLINE INC-CL A | 28.94 | 57.014B | ||
| ALGN | ALIGN TECHNOLOGY INC | 14.23 | 12.777B | ||
| COO | COOPER COS INC/THE | 12.09 | 11.968B | ||
| SOLV | SOLVENTUM CORP | 10.1 | 11.53B | ||
| LNTH | LANTHEUS HOLDINGS INC | 15.32 | 5.274B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 15.69 | 3.868B | ||
| ICUI | ICU MEDICAL INC | 13.95 | 2.885B | ||
| HAE | HAEMONETICS CORP/MASS | 11.14 | 2.742B | ||
| XRAY | DENTSPLY SIRONA INC | 7.86 | 2.293B | ||
| NEOG | NEOGEN CORP | 26.57 | 1.961B | ||
| UFPT | UFP TECHNOLOGIES INC | 18.4 | 1.43B | ||
| STAA | STAAR SURGICAL CO | N/A | 1.262B | ||
| AVNS | AVANOS MEDICAL INC | 24.14 | 1.146B |
Related stock screener links
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About RXST
Company Profile
RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. The company is headquartered in Aliso Viejo, California and currently employs 461 full-time employees. The company went IPO on 2021-07-30. The firm's proprietary RxSight Light Adjustable Lens system (RxSight system) is commercially available premium cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system consists of its RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. In contrast, with the RxSight system, the surgeon implants the LAL during a standard cataract procedure, determines refractive error with patient input several weeks following surgery and then uses the LDD to modify the LAL with the precise visual correction needed to achieve the patient's desired vision outcomes.
Company Info
IPO: 2021-07-30
RXSIGHT INC
100 Columbia Street, Suite 120
Aliso Viejo CALIFORNIA US
CEO: Ron Kurtz
Employees: 461
Phone: 19495217822
RXSIGHT INC / RXST FAQ
What does RXSIGHT INC do?
RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. The company is headquartered in Aliso Viejo, California and currently employs 461 full-time employees. The company went IPO on 2021-07-30. The firm's proprietary RxSight Light Adjustable Lens system (RxSight system) is commercially available premium cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system consists of its RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. In contrast, with the RxSight system, the surgeon implants the LAL during a standard cataract procedure, determines refractive error with patient input several weeks following surgery and then uses the LDD to modify the LAL with the precise visual correction needed to achieve the patient's desired vision outcomes.
What is the current price of RXST stock?
The current stock price of RXST is 6.81 USD. The price decreased by -5.02% in the last trading session.
Does RXSIGHT INC pay dividends?
RXST does not pay a dividend.
What is the ChartMill rating of RXSIGHT INC stock?
RXST has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Which stock exchange lists RXST stock?
RXST stock is listed on the Nasdaq exchange.
What is the Price/Earnings (PE) ratio of RXSIGHT INC (RXST)?
RXSIGHT INC (RXST) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.95).